The role of periostin in tissue remodeling across health and disease
- PMID: 24146092
- PMCID: PMC3949008
- DOI: 10.1007/s00018-013-1494-y
The role of periostin in tissue remodeling across health and disease
Abstract
Periostin, also termed osteoblast-specific factor 2, is a matricellular protein with known functions in osteology, tissue repair, oncology, cardiovascular and respiratory systems, and in various inflammatory settings. However, most of the research to date has been conducted in divergent and circumscribed areas meaning that the overall understanding of this intriguing molecule remains fragmented. Here, we integrate the available evidence on periostin expression, its normal role in development, and whether it plays a similar function during pathologic repair, regeneration, and disease in order to bring together the different research fields in which periostin investigations are ongoing. In spite of the seemingly disparate roles of periostin in health and disease, tissue remodeling as a response to insult/injury is emerging as a common functional denominator of this matricellular molecule. Periostin is transiently upregulated during cell fate changes, either physiologic or pathologic. Combining observations from various conditions, a common pattern of events can be suggested, including periostin localization during development, insult and injury, epithelial-mesenchymal transition, extracellular matrix restructuring, and remodeling. We propose mesenchymal remodeling as an overarching role for the matricellular protein periostin, across physiology and disease. Periostin may be seen as an important structural mediator, balancing appropriate versus inappropriate tissue adaption in response to insult/injury.
Conflict of interest statement
Kenji Izuhara has received a patent license fee from F. Hoffmann-La Roche Ltd, a personal consultant fee and grant from Chugai Pharmaceutical Co. Ltd, and a grant from Shino-test Co. Ltd. Judith Litvin, Roger Markwald, Simon J. Conway, Gaoliang Ouyang, Yasusei Kudo, Akira Kudo, have no conflict of interest. Joseph R. Arron and Cecile T.J. Holweg are employees of Genentech, a member of the Roche group and have an equity interest in Roche.
Figures
References
-
- Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14:1239–1249. - PubMed
-
- Zinn K, McAllister L, Goodman CS. Sequence analysis and neuronal expression of fasciclin I in grasshopper and Drosophila . Cell. 1988;53:577–587. - PubMed
-
- Terasaka K, Yamaguchi R, Matsuo K, Yamazaki A, Nagai S, Yamada T. Complete nucleotide sequence of immunogenic protein MPB70 from Mycobacterium bovis BCG. FEMS Microbiol Lett. 1989;49:273–276. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
